These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31491513)

  • 1. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis.
    Wang X; Shi L; Wang X; Feng Y; Wang Y
    Int J Biol Macromol; 2019 Dec; 141():1013-1021. PubMed ID: 31491513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.
    Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y
    Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids.
    Shi L; Wang J; Wang Y; Feng Y
    Carbohydr Polym; 2016 Oct; 150():74-81. PubMed ID: 27312615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDG-1, a polysaccharide from Ophiopogon japonicus, prevents high fat diet-induced obesity and increases energy expenditure in mice.
    Wang Y; Zhu Y; Ruan K; Wei H; Feng Y
    Carbohydr Polym; 2014 Dec; 114():183-189. PubMed ID: 25263880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice.
    Shi LL; Li Y; Wang Y; Feng Y
    Int J Biol Macromol; 2015 Nov; 81():576-83. PubMed ID: 26321425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS).
    Zhu Y; Cong W; Shen L; Wei H; Wang Y; Wang L; Ruan K; Wu F; Feng Y
    Mol Biosyst; 2014 Feb; 10(2):304-12. PubMed ID: 24292023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
    Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
    Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
    Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice.
    Wang X; Shi L; Joyce S; Wang Y; Feng Y
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
    Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling.
    Peng CH; Yang MY; Yang YS; Yu CC; Wang CJ
    Am J Chin Med; 2017; 45(1):67-83. PubMed ID: 28161992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of MDG-1, a polysaccharide from Ophiopogon japonicas, on diversity of lactobacillus in diet-induced obese mice].
    Shi LL; Wang Y; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):716-21. PubMed ID: 26137696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
    Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
    J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways.
    Wu J; Shao H; Zhang J; Ying Y; Cheng Y; Zhao D; Dou X; Lv H; Li S; Liu F; Ling P
    Int J Biol Macromol; 2019 Jun; 130():68-78. PubMed ID: 30797009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.